All-trans retinoic acid induces cellular senescence via upregulation of p16, p21, and p27

Cancer Letters

Volumn 310, Issue 2, 2011, Pages 232-239

  Park, Sun Hye ^a   Lim, Joo Song ^a   Jang, Kyung Lib ^a  

^a Pusan National University   (South Korea)

Author keywords

All trans retinoic acid; Cellular senescence; P16; P21; P27

Indexed keywords

BETA GALACTOSIDASE; GAMMA TUBULIN; PROTEIN P16; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; RETINOIC ACID; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL SPECIFICITY; CELL STRAIN HCT116; CELL STRAIN HEPG2; CELL STRAIN HUH7; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE SILENCING; GROWTH INHIBITION; HETEROCHROMATIN; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; RNA INTERFERENCE; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL AGING; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HEP G2 CELLS; HUMANS; NEOPLASM PROTEINS; TRANSFECTION; TRETINOIN; UP-REGULATION;

EID: 80051703039     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.009     Document Type: Article

References (38)

1. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996, 10:940-954.
2. Hansen L.A., Sigman C.C., Andreola F., Ross S.A., Kelloff G.J., De Luca L.M. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000, 21:1271-1279.
3. Higginbotham K.B., Lozano R., Brown T., Patt Y.Z., Arima T., Abbruzzese J.L., Thomas M.B. A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2008, 134:1325-1335.
4. Ito K., Utsunomiya H., Niikura H., Yaegashi N., Sasano H. Inhibition of estrogen actions in human gynecological malignancies: new aspects of endocrine therapy for endometrial cancer and ovarian cancer. Mol. Cell. Endocrinol. 2011, 340:161-167.
5. Reynolds C.P., Matthay K.K., Villablanca J.G., Maurer B.J. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 2003, 197:185-192.
6. Shimizu M., Sakai H., Moriwaki H. Chemoprevention of hepatocellular carcinoma by acyclic retinoid. Front Biosci. 2011, 16:759-769.
7. Zhang X., Chen Z.G., Khuri F.R., Shin D.M. Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck. Head Neck 2007, 29:351-361.
8. Campisi J. Suppressing cancer: the importance of being senescent. Science 2005, 309:886-887.
9. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 1995, 92:9363-9367.
10. Narita M., Nunez S., Heard E., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
11. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., Sharrocks A.D., Peters G., Hara E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 2001, 409:1067-1070.
12. Dimberg A., Bahram F., Karlberg I., Larsson L.G., Nilsson K., Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 2002, 99:2199-2206.
13. Seo S.Y., Kim E.O., Jang K.L. Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation. Cancer Lett. 2008, 270:66-76.
14. Jung J.K., Park S.H., Jang K.L. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation. J. Gen. Virol. 2010, 91:493-500.
15. Lee C.W., Sorensen T.S., Shikama N., La Thangue N.B. Functional interplay between p53 and E2F through co-activator p300. Oncogene 1998, 16:2695-2710.
16. Bond J., Jones C., Haughton M., DeMicco C., Kipling D., Wynford-Thomas D. Direct evidence from siRNA-directed "knock down" that p16(INK4a) is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation. Exp. Cell. Res. 2004, 292:151-156.
17. Rao A., Coan A., Welsh J.E., Barclay W.W., Koumenis C., Cramer S.D. Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Res. 2004, 64:2143-2147.
18. Itoh Y., Masuyama N., Nakayama K., Nakayama K., Gotoh Y. The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex. J. Biol. Chem. 2007, 282:390-396.
19. 2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J. Biol. Chem. 2001, 276:2531-2537.
20. Jung J.K., Arora P., Pagano J.S., Jang K.L. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 2007, 67:5771-5778.
21. Pichiorri F., Suh S.-S., Ladetto M., Kuehl M., Palumbo T., Drandi D., Taccioli C., Zanesi N., Alder H., Hagan J.P., Munker R., Volinia S., Boccadoro M., Garzon R., Palumbo A., Ageilan R.I., Croce C.M. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl. Acad. Sci. USA 2008, 105:12885-12890.
22. Liu Y., Lee M.O., Wang H.G., Li Y., Hashimoto Y., Klaus M., Reed J.C., Zhang X. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol. 1996, 16:1138-1149.
23. Congleton J., Jiang H., Malavasi F., Lin H., Yen A. ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary. Exp. Cell. Res. 2011, 317:910-919.
24. Bringold F., Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 2000, 35:317-329.
25. de The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15; 17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990, 347:558-561.
26. Lotan Y., Lotan R. Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?. Cancer Biol. Ther. 2008, 7:101-102.
27. Trojanowicz B., Sekulla C., Lorenz K., Kohrle J., Finke R., Dralle H., Hoang-Vu C. Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma. Mol. Cell. Endocrinol. 2010, 325:110-117.
28. Hui A.M., Shi Y.Z., Li X., Takayama T., Makuuchi M. Loss of p16(INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression. Cancer Lett. 2000, 154:93-99.
29. Petitjean A., Cavard C., Shi H., Tribollet V., Hainaut P., Caron de Fromentel C. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Oncogene 2005, 24:512-519.
30. Grand R.J., Lecane P.S., Owen D., Grant M.L., Roberts S., Levine A.J., Gallimore P.H. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Virology 1995, 210:323-334.
31. Hashimoto O., Ueno T., Kimura R., Ohtubo M., Nakamura T., Koga H., Torimura T., Uchida S., Yamashita K., Sata M. Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1. Mol. Carcinog. 2003, 36:171-182.
32. Myohanen S.K., Baylin S.B., Herman J.G. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res. 1998, 58:591-593.
33. Xu X.C. Tumor-suppressive activity of retinoic acid receptor-beta in cancer. Cancer Lett. 2007, 253:14-24.
34. Tanaka T., Suh K.S., Lo A.M., De Luca L.M. p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer. J. Biol. Chem. 2007, 282:29987-29997.
35. Zheng P.Z., Wang K.K., Zhang Q.Y., Huang Q.H., Du Y.Z., Zhang Q.H., Xiao D.K., Shen S.H., Imbeaud S., Eveno E., Zhao C.J., Chen Y.L., Fan H.Y., Waxman S., Auffray C., Jin G., Chen S.J., Chen Z., Zhang J. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 2005, 102:7653-7658.
36. vom Baur E., Zechel C., Heery D., Heine M.J., Garnier J.M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 1996, 15:110-124.
37. Boyle J.O., Langenfeld J., Lonardo F., Sekula D., Reczek P., Rusch V., Dawson M.I., Dmitrovsky E. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J. Natl. Cancer Inst. 1999, 91:373-379.
38. Nakanishi M., Tomaru Y., Miura H., Hayashizaki Y., Suzuki M. Identification of transcriptional regulatory cascades in retinoic acid-induced growth arrest of HepG2 cells. Nucl. Acids Res. 2008, 36:3443-3454.